Propofol
| Subclass of | chemical compound |
|---|---|
| Get use | Medication |
| Chemical formula | C₁₂H₁₈O |
| Canonical SMILES | CC(C)C1=C(C(=CC=C1)C(C)C)O |
| Active ingredient in | Diprivan |
| World Health Organisation international non-proprietary name | propofol, propofolum |
| Medical condition treated | pain, agitation in dementia, status epilepticus, subacute delirium, anaesthesia |
| Physically dey interact plus | Hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
| Pregnancy category | Australian pregnancy category C, US pregnancy category B |
| Manufacturer | Pfizer |
| Subject has role | GABAA receptor positive allosteric modulators, hypnotics and sedatives, intravenous anesthetics, essential medicine |
Propofol[1] be de active component of an intravenous anesthetic formulation dem use for induction den maintenance of general anesthesia. Na dem approve de formulation under de brand name Diprivan. Na dem since release chaw generic versions. Dem use intravenous administration to induce unconsciousness, after wich dem fi maintain anesthesia dey use a combination of medications. Na dem manufacture am as part of a sterile injectable emulsion formulation dey use soybean oil den lecithin, wey dey give am a white milky coloration.[2]
Dem compare to oda anesthetic agents, recovery from propofol-induced anesthesia generally be rapid wey be associated plus less frequent side effects[3][4] (e.g., drowsiness, nausea, vomiting). Dem fi use propofol prior to diagnostic procedures wey dey require anesthesia, insyd de management of refractory status epilepticus, den for induction anaa maintenance of anesthesia prior to den during surgeries. E fi be administered as a bolus anaa an infusion, anaa as a combination of de two.
Dem first synthesize am insyd 1973 by John B. Glen, a British veterinary anesthesiologist wey dey work give Imperial Chemical Industries (ICI, later AstraZeneca),[5] na dem introduce propofol for therapeutic use as a lipid emulsion insyd de United Kingdom den New Zealand insyd 1986. Na propofol (Diprivan) receive FDA approval insyd October 1989. E be on de World Health Organization's List of Essential Medicines.[6]
References
[edit | edit source]- ↑ "Propofol". PubChem. U.S. National Library of Medicine. Retrieved 25 October 2023.
- ↑ "Making Stable, Sterile Propofol". www.microfluidics-mpt.com. Retrieved 25 October 2023.
- ↑ "Propofol". go.drugbank.com. Retrieved 25 October 2023.
- ↑ Glen JB (September 2018). "The Discovery and Development of Propofol Anesthesia: The 2018 Lasker-DeBakey Clinical Medical Research Award". JAMA. 320 (12): 1235–1236. doi:10.1001/jama.2018.12756. PMID 30208399.
- ↑ Glen JB (July 2019). "Try, try, and try again: personal reflections on the development of propofol". British Journal of Anaesthesia. 123 (1): 3–9. doi:10.1016/j.bja.2019.02.031. PMID 30982566.
- ↑ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
External links
[edit | edit source]- GB patent 1472793, John B. Glen; Roger James & Bob-James Munroe, "Pharmaceutical Compositions", published 1977-05-04, assigned to Imperial Chemical Industries Ltd Archived 5 June 2021 at the Wayback Machine
- CS1:Vancouver names with accept markup
- Translated from MDWiki
- Commons category link from Wikidata
- Webarchive template wayback links
- Drugs wey AstraZeneca develop
- Chemical substances for emergency medicine
- Dog medications
- General anesthetics
- GABAA receptor positive allosteric modulators
- GABAA receptor agonists
- Glycine receptor agonists
- Alkylphenols
- World Health Organization essential medicines
- Isopropyl compounds